These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37145099)

  • 21. Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Kayali R; Ku JM; Khitrov G; Jung ME; Prikhodko O; Bertoni C
    Hum Mol Genet; 2012 Sep; 21(18):4007-20. PubMed ID: 22692682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Frontline studies on Duchenne muscular dystrophy treatment].
    Matsuo M
    No To Hattatsu; 2009 Mar; 41(2):92-5. PubMed ID: 19517771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations.
    Bladen CL; Salgado D; Monges S; Foncuberta ME; Kekou K; Kosma K; Dawkins H; Lamont L; Roy AJ; Chamova T; Guergueltcheva V; Chan S; Korngut L; Campbell C; Dai Y; Wang J; Barišić N; Brabec P; Lahdetie J; Walter MC; Schreiber-Katz O; Karcagi V; Garami M; Viswanathan V; Bayat F; Buccella F; Kimura E; Koeks Z; van den Bergen JC; Rodrigues M; Roxburgh R; Lusakowska A; Kostera-Pruszczyk A; Zimowski J; Santos R; Neagu E; Artemieva S; Rasic VM; Vojinovic D; Posada M; Bloetzer C; Jeannet PY; Joncourt F; Díaz-Manera J; Gallardo E; Karaduman AA; Topaloğlu H; El Sherif R; Stringer A; Shatillo AV; Martin AS; Peay HL; Bellgard MI; Kirschner J; Flanigan KM; Straub V; Bushby K; Verschuuren J; Aartsma-Rus A; Béroud C; Lochmüller H
    Hum Mutat; 2015 Apr; 36(4):395-402. PubMed ID: 25604253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Readthrough strategies for stop codons in Duchenne muscular dystrophy.
    Aurino S; Nigro V
    Acta Myol; 2006 Jun; 25(1):5-12. PubMed ID: 17039975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy.
    Mah JK
    Methods Mol Biol; 2018; 1687():3-17. PubMed ID: 29067652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duchenne and Becker muscular dystrophy: contribution of a molecular and immunohistochemical analysis in diagnosis in Morocco.
    Bellayou H; Hamzi K; Rafai MA; Karkouri M; Slassi I; Azeddoug H; Nadifi S
    J Biomed Biotechnol; 2009; 2009():325210. PubMed ID: 19461958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive genetic characteristics of dystrophinopathies in China.
    Ma P; Zhang S; Zhang H; Fang S; Dong Y; Zhang Y; Hao W; Wu S; Zhao Y
    Orphanet J Rare Dis; 2018 Jul; 13(1):109. PubMed ID: 29973226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of dystrophin mRNA from skeletal muscle but not from lymphocytes led to identification of a novel nonsense mutation in a carrier of Duchenne muscular dystrophy.
    Ito T; Takeshima Y; Yagi M; Kamei S; Wada H; Nakamura H; Matsuo M
    J Neurol; 2003 May; 250(5):581-7. PubMed ID: 12736738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.
    Hoffman EP
    Acta Myol; 2020 Dec; 39(4):179-186. PubMed ID: 33458572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].
    den Dunnen JT; de Visser M; Bakker E
    Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples.
    Sardone V; Ellis M; Torelli S; Feng L; Chambers D; Eastwood D; Sewry C; Phadke R; Morgan JE; Muntoni F
    PLoS One; 2018; 13(3):e0194540. PubMed ID: 29579078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nonsense readthrough therapy for Duchenne muscular dystrophy].
    Takeshima Y
    Rinsho Shinkeigaku; 2014; 54(12):1074-6. PubMed ID: 25672712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mutation screening of 433 families with Duchenne/Becker muscular dystrophy].
    Bai Y; Li S; Zong YN; Li XL; Zhao ZH; Kong XD
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(16):1261-9. PubMed ID: 27122458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular therapies for Duchenne muscular dystrophy].
    Takeshima Y
    No To Hattatsu; 2016 Jul; 48(4):241-6. PubMed ID: 30010301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application whole exome sequencing for the clinical molecular diagnosis of patients with Duchenne muscular dystrophy; identification of four novel nonsense mutations in four unrelated Chinese DMD patients.
    Zhang Y; Yang W; Wen G; Wu Y; Jing Z; Li D; Tang M; Liu G; Wei X; Zhong Y; Li Y; Deng Y
    Mol Genet Genomic Med; 2019 May; 7(5):e622. PubMed ID: 30938079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoring dystrophin expression in duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through.
    Hoffman EP; Bronson A; Levin AA; Takeda S; Yokota T; Baudy AR; Connor EM
    Am J Pathol; 2011 Jul; 179(1):12-22. PubMed ID: 21703390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene.
    Deburgrave N; Daoud F; Llense S; Barbot JC; Récan D; Peccate C; Burghes AH; Béroud C; Garcia L; Kaplan JC; Chelly J; Leturcq F
    Hum Mutat; 2007 Feb; 28(2):183-95. PubMed ID: 17041906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping.
    Anthony K; Arechavala-Gomeza V; Ricotti V; Torelli S; Feng L; Janghra N; Tasca G; Guglieri M; Barresi R; Armaroli A; Ferlini A; Bushby K; Straub V; Ricci E; Sewry C; Morgan J; Muntoni F
    JAMA Neurol; 2014 Jan; 71(1):32-40. PubMed ID: 24217213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.